Breast cancer

January 5, 2023

Trial Results: The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy

The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
September 26, 2022

For people with stage 4 cancer, survivorship is complicated

Robin Evans, a research advocate with the ECOG-ACRIN Cancer Research Group, shares her perspective on navigating the survivorship community as someone living with stage 4 cancer
September 26, 2022

Trial Results: ECOG-ACRIN research round-up – Fall 2022

Summaries of recently reported ECOG-ACRIN research results
June 28, 2022

Unconscious bias among physicians creates obstacles to genetic counseling and testing for Black women with breast cancer

A nationwide survey found that doctors’ beliefs and practices regarding genetic counseling and testing varied by race